Cadrenal Therapeutics CMO resigns, separation terms disclosed

Go back to Cadrenal Therapeutics CMO resigns, separation terms disclosed

Form 8-K Cadrenal Therapeutics, For: Jul 14

July 17, 2026 4:15 PM EDT

false 0001937993 0001937993 2026-07-14 2026-07-14 iso4217:USD xbrli:shares iso4217:USD... More